New grad roles at Vor Bio
Vor Bio is a clinical-stage biotechnology company developing telitacicept, a dual-target fusion protein for serious autoantibody-driven autoimmune diseases. The company is advancing the therapy through global Phase 3 clinical development and commercialization, with commercial approvals in China.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 3
No current roles
Check back soon.
Get new Vor Bio new grad roles by email
Free account. Get new Vor Bio new grad roles by email or push the minute they post.
